187 related articles for article (PubMed ID: 9848887)
21. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
22. Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis.
O'Brien KD; Lewis K; Fischer JW; Johnson P; Hwang JY; Knopp EA; Kinsella MG; Barrett PH; Chait A; Wight TN
Atherosclerosis; 2004 Nov; 177(1):29-35. PubMed ID: 15488862
[TBL] [Abstract][Full Text] [Related]
23. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties.
Chang MY; Potter-Perigo S; Tsoi C; Chait A; Wight TN
J Biol Chem; 2000 Feb; 275(7):4766-73. PubMed ID: 10671509
[TBL] [Abstract][Full Text] [Related]
24. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells.
Koyama N; Kinsella MG; Wight TN; Hedin U; Clowes AW
Circ Res; 1998 Aug; 83(3):305-13. PubMed ID: 9710123
[TBL] [Abstract][Full Text] [Related]
25. Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein.
Kaplan M; Aviram M
Atherosclerosis; 2000 Mar; 149(1):5-17. PubMed ID: 10704609
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions.
Sartipy P; Johansen B; Gâsvik K; Hurt-Camejo E
Circ Res; 2000 Mar; 86(6):707-14. PubMed ID: 10747008
[TBL] [Abstract][Full Text] [Related]
27. Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs.
Little PJ; Tannock L; Olin KL; Chait A; Wight TN
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):55-60. PubMed ID: 11788461
[TBL] [Abstract][Full Text] [Related]
28. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
29. Macrophages bind LDL using heparan sulfate and the perlecan protein core.
Ng CY; Whitelock JM; Williams H; Kim HN; Medbury HJ; Lord MS
J Biol Chem; 2021; 296():100520. PubMed ID: 33684447
[TBL] [Abstract][Full Text] [Related]
30. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans.
Oörni K; Hakala JK; Annila A; Ala-Korpela M; Kovanen PT
J Biol Chem; 1998 Oct; 273(44):29127-34. PubMed ID: 9786921
[TBL] [Abstract][Full Text] [Related]
31. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.
Hurt-Camejo E; Camejo G; Rosengren B; López F; Ahlström C; Fager G; Bondjers G
Arterioscler Thromb; 1992 May; 12(5):569-83. PubMed ID: 1576119
[TBL] [Abstract][Full Text] [Related]
32. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins.
Olsson U; Bondjers G; Camejo G
Diabetes; 1999 Mar; 48(3):616-22. PubMed ID: 10078565
[TBL] [Abstract][Full Text] [Related]
33. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis.
Fogelstrand P; Borén J
Nutr Metab Cardiovasc Dis; 2012 Jan; 22(1):1-7. PubMed ID: 22176921
[TBL] [Abstract][Full Text] [Related]
34. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis.
Higazi AA; Nassar T; Ganz T; Rader DJ; Udassin R; Bdeir K; Hiss E; Sachais BS; Williams KJ; Leitersdorf E; Cines DB
Blood; 2000 Aug; 96(4):1393-8. PubMed ID: 10942383
[TBL] [Abstract][Full Text] [Related]
35. Elevated expression of proteoglycans in proliferating vascular smooth muscle cells.
Tao Z; Smart FW; Figueroa JE; Glancy DL; Vijayagopal P
Atherosclerosis; 1997 Dec; 135(2):171-9. PubMed ID: 9430366
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E mediates the retention of high-density lipoproteins by mouse carotid arteries and cultured arterial smooth muscle cell extracellular matrices.
Olin-Lewis K; Benton JL; Rutledge JC; Baskin DG; Wight TN; Chait A
Circ Res; 2002 Jun; 90(12):1333-9. PubMed ID: 12089072
[TBL] [Abstract][Full Text] [Related]
37. Red wine administration to apolipoprotein E-deficient mice reduces their macrophage-derived extracellular matrix atherogenic properties.
Kaplan M; Aviram M
Biol Res; 2004; 37(2):239-45. PubMed ID: 15455653
[TBL] [Abstract][Full Text] [Related]
38. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells.
Camejo G; Fager G; Rosengren B; Hurt-Camejo E; Bondjers G
J Biol Chem; 1993 Jul; 268(19):14131-7. PubMed ID: 8314779
[TBL] [Abstract][Full Text] [Related]
39. Marked alteration of proteoglycan metabolism in cholesterol-enriched human arterial smooth muscle cells.
Vijayagopal P; Figueroa JE; Guo Q; Fontenot JD; Tao Z
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):995-1000. PubMed ID: 8645189
[TBL] [Abstract][Full Text] [Related]
40. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
